April 5 (Reuters) - Boehringer Ingelheim on Thursday said it will lay off some of its U.S. salesforce due to poor sales there of its biosimilar version of AbbVie’s blockbuster arthritis treatment ...
Seattle-based Sana Biotechnology Inc. (Nasdaq: SANA) is losing its research and development lead. In a Thursday filing with ...
The Westchester-based unit of New Jersey-based Kenvue is closing its corporate headquarters at 6080 West Center Drive to ...
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from ...
US stocks were mostly lower on Thursday with the S&P 500 and Nasdaq falling for the fifth straight day as another rise in ...
Q4 2023 Earnings Call April 24, 2024 CureVac N.V. isn’t one of the 30 most popular stocks among hedge funds at the end of the ...
Wall Street stocks were in the green early on Monday as retail sales boosted sentiment and market participants prepared for ...
In this article, we will take a detailed look at Jim Cramer's 10 Favorite Healthcare Stock Picks in 2024. For a quick ...